Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Similar articles for PubMed (Select 24337061)

1.

TWEAK/Fn14 signaling mediates gastric cancer cell resistance to 5-fluorouracil via NF-κB activation.

Kwon OH, Kim JH, Kim SY, Kim YS.

Int J Oncol. 2014 Feb;44(2):583-90. doi: 10.3892/ijo.2013.2211. Epub 2013 Dec 9.

PMID:
24337061
2.

Transcription Factor AP2∊: A Potential Predictor of Chemoresistance in Patients With Gastric Cancer.

Sun J, Du N, Li J, Zhou J, Tao G, Sun S, He J.

Technol Cancer Res Treat. 2015 Mar 25. pii: 1533034615577028. [Epub ahead of print]

PMID:
25810491
3.

APRIL induces cisplatin resistance in gastric cancer cells via activation of the NF-κB pathway.

Zhi X, Tao J, Xiang G, Cao H, Liu Z, Yang K, Lv C, Ni S.

Cell Physiol Biochem. 2015;35(2):571-85. doi: 10.1159/000369720. Epub 2015 Jan 27.

PMID:
25612651
4.

Silencing of the ABCC4 gene by RNA interference reverses multidrug resistance in human gastric cancer.

Zhang G, Wang Z, Qian F, Zhao C, Sun C.

Oncol Rep. 2015 Mar;33(3):1147-54. doi: 10.3892/or.2014.3702. Epub 2014 Dec 30.

PMID:
25572969
5.

TWEAK-Fn14 pathway activation after exercise in human skeletal muscle: insights from two exercise modes and a time course investigation.

Raue U, Jemiolo B, Yang Y, Trappe S.

J Appl Physiol (1985). 2015 Mar 1;118(5):569-78. doi: 10.1152/japplphysiol.00759.2014. Epub 2014 Dec 24.

PMID:
25539934
6.

MiR-22 regulates 5-FU sensitivity by inhibiting autophagy and promoting apoptosis in colorectal cancer cells.

Zhang H, Tang J, Li C, Kong J, Wang J, Wu Y, Xu E, Lai M.

Cancer Lett. 2015 Jan 28;356(2 Pt B):781-90. doi: 10.1016/j.canlet.2014.10.029. Epub 2014 Oct 29.

PMID:
25449431
7.

Preparation of 5-fluorouracil-loaded nanoparticles and study of interaction with gastric cancer cells.

Fan YL, Fan BY, Li Q, Di HX, Meng XY, Ling N.

Asian Pac J Cancer Prev. 2014;15(18):7611-5.

8.

tRNA modifying enzymes, NSUN2 and METTL1, determine sensitivity to 5-fluorouracil in HeLa cells.

Okamoto M, Fujiwara M, Hori M, Okada K, Yazama F, Konishi H, Xiao Y, Qi G, Shimamoto F, Ota T, Temme A, Tatsuka M.

PLoS Genet. 2014 Sep 18;10(9):e1004639. doi: 10.1371/journal.pgen.1004639. eCollection 2014 Sep.

9.

Overexpression of CD133 enhances chemoresistance to 5-fluorouracil by activating the PI3K/Akt/p70S6K pathway in gastric cancer cells.

Zhu Y, Yu J, Wang S, Lu R, Wu J, Jiang B.

Oncol Rep. 2014 Dec;32(6):2437-44. doi: 10.3892/or.2014.3488. Epub 2014 Sep 17.

PMID:
25230779
10.

Fibroblast growth factor-inducible 14 regulates cell growth and multidrug resistance of small-cell lung cancer through the nuclear factor-κB pathway.

Li X, Zhu W, Chen Z, Luo L, Huang J, Zhang F, Li M, Guo Y, Guo L.

Anticancer Drugs. 2014 Nov;25(10):1152-64. doi: 10.1097/CAD.0000000000000153.

PMID:
25054270
11.

Overexpression of microRNA-122 re-sensitizes 5-FU-resistant colon cancer cells to 5-FU through the inhibition of PKM2 in vitro and in vivo.

He J, Xie G, Tong J, Peng Y, Huang H, Li J, Wang N, Liang H.

Cell Biochem Biophys. 2014 Nov;70(2):1343-50. doi: 10.1007/s12013-014-0062-x.

PMID:
24898807
12.

A compensatory role of NF-κB to p53 in response to 5-FU-based chemotherapy for gastric cancer cell lines.

Endo F, Nishizuka SS, Kume K, Ishida K, Katagiri H, Ishida K, Sato K, Iwaya T, Koeda K, Wakabayashi G.

PLoS One. 2014 Feb 27;9(2):e90155. doi: 10.1371/journal.pone.0090155. eCollection 2014.

13.

Mcl-1 mediates TWEAK/Fn14-induced non-small cell lung cancer survival and therapeutic response.

Whitsett TG, Mathews IT, Cardone MH, Lena RJ, Pierceall WE, Bittner M, Sima C, LoBello J, Weiss GJ, Tran NL.

Mol Cancer Res. 2014 Apr;12(4):550-9. doi: 10.1158/1541-7786.MCR-13-0458. Epub 2014 Jan 27.

14.

Overexpression of fibronectin confers cell adhesion-mediated drug resistance (CAM-DR) against 5-FU in oral squamous cell carcinoma cells.

Nakagawa Y, Nakayama H, Nagata M, Yoshida R, Kawahara K, Hirosue A, Tanaka T, Yuno A, Matsuoka Y, Kojima T, Yoshitake Y, Hiraki A, Shinohara M.

Int J Oncol. 2014 Apr;44(4):1376-84. doi: 10.3892/ijo.2014.2265. Epub 2014 Jan 21.

PMID:
24452447
15.

TWEAK/Fn14 pathway is a novel mediator of retinal neovascularization.

Ameri H, Liu H, Liu R, Ha Y, Paulucci-Holthauzen AA, Hu S, Motamedi M, Godley BF, Tilton RG, Zhang W.

Invest Ophthalmol Vis Sci. 2014 Feb 10;55(2):801-13. doi: 10.1167/iovs.13-12812.

16.

Amelioration of cancer stem cells in macrophage colony stimulating factor-expressing U87MG-human glioblastoma upon 5-fluorouracil therapy.

Chockalingam S, Ghosh SS.

PLoS One. 2013 Dec 31;8(12):e83877. doi: 10.1371/journal.pone.0083877. eCollection 2013.

17.

Knockdown of MDR1 increases the sensitivity to adriamycin in drug resistant gastric cancer cells.

Zhu CY, Lv YP, Yan DF, Gao FL.

Asian Pac J Cancer Prev. 2013;14(11):6757-60.

18.

Txr1: an important factor in oxaliplatin resistance in gastric cancer.

Bi J, Bai Z, Ma X, Song J, Guo Y, Zhao J, Yi X, Han S, Zhang Z.

Med Oncol. 2014 Feb;31(2):807. doi: 10.1007/s12032-013-0807-1. Epub 2013 Dec 21.

PMID:
24362794
19.

Nrf2 overexpression predicts prognosis and 5-FU resistance in gastric cancer.

Hu XF, Yao J, Gao SG, Wang XS, Peng XQ, Yang YT, Feng XS.

Asian Pac J Cancer Prev. 2013;14(9):5231-5.

20.

Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.

Sun XP, Dong X, Lin L, Jiang X, Wei Z, Zhai B, Sun B, Zhang Q, Wang X, Jiang H, Krissansen GW, Qiao H, Sun X.

FEBS J. 2014 Jan;281(1):115-28. doi: 10.1111/febs.12577. Epub 2013 Nov 18.

PMID:
24165223
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk